What is Castle Biosciences's net change in cash?

Castle Biosciences (CSTL) reported net change in cash of -$52.97M in Q1 2026.

How has Castle Biosciences's net change in cash changed year-over-year?

Castle Biosciences's net change in cash decreased by 76.4% year-over-year, from -$30.02M to -$52.97M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Castle Biosciences CSTL Net Change in Cash

Net Change in Cash at other companies

Labcorp HoldingsLH

$448.8M+139%

VeracyteVCYT

-$99.43M-88.1%

Personalis, Inc.PSNL

-$50.65M-148%

NeoGenomicsNEO

-$13.48M+35.3%

Fulgent Genetics, Inc.FLGT

-$26.79M-321%

Cogent Biosciences, Inc.COGT

-$70.8M-354%

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's net change in cash?: Castle Biosciences (CSTL) reported net change in cash of -$52.97M in Q1 2026.
How has Castle Biosciences's net change in cash changed year-over-year?: Castle Biosciences's net change in cash decreased by 76.4% year-over-year, from -$30.02M to -$52.97M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.